Administration Time-dependent Antihypertensive Effects of Low Dose Aspirin in Well-controlled Hypertensive Patients
A Multi-center, Double-Blind Randomized, Cross-over, Active-control, Comparative Clinical Study to Evaluate the Administration Time-dependent Antihypertensive Effects of Low Dose Aspirin in Well-Controlled Hypertensive Patients (Phase IV)
1 other identifier
interventional
191
1 country
1
Brief Summary
The purpose of this study is to evaluate the influence of aspirin on blood pressure in well-controlled hypertensive patients who receive low dose aspirin at different times of the day
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_4
Started Sep 2006
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2006
CompletedFirst Submitted
Initial submission to the registry
October 9, 2006
CompletedFirst Posted
Study publicly available on registry
October 11, 2006
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2007
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2008
CompletedDecember 15, 2010
December 1, 2010
4 months
October 9, 2006
December 14, 2010
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
the changes in diastolic blood pressure
Secondary Outcomes (3)
the changes in systolic blood pressure
the trend in home blood pressure for medication
the comparison of the changes in systolic and diastolic pressure in dipper and non-dipper patients
Interventions
Eligibility Criteria
You may qualify if:
- Age : 30 - 70 (inclusive)
- Essential hypertension without complication
- Well-controlled blood pressure over 3 months with same antihypertensive medication without changes in dose and frequency
- Averages of two consecutive sitting diastolic and systolic blood pressures are \<90 mmHg and \<140 mmHg, respectively at screening and visit 1
- Differences in sitting diastolic and systolic blood pressures between screening and visit 1 are 10 mmHg and 20 mmHg, respectively.
- Willing and able to give informed consent
You may not qualify if:
- patients with sitting diastolic blood pressure \< 70 mmHg
- patients with secondary or malignant hypertension
- patients with complication or high risk of complication
- proven coronary artery or peripheral vascular diseases
- Framingham CHD Risk Score (10 years) 20
- Fasting blood glucose 110 mg/dl
- Hyperlipidemia under treatment or treatment required
- patients with myocardial infarction or severe cerebrovascular disorder in last 6 months
- patients with chronic renal insufficiency
- patients with unstable angina
- patients with severe left ventricular abnormalities or valvular defect
- patients with bradycardia(pulse rate \< 50 times/min) or chronic tachycardia (pulse rate 100 times/min), second degree AV-block
- SGOT, SGPT\> 2.5 times upper limit range or serum creatinine \> 1.5 times upper limit range
- patients with unresolved malignant tumor or systemic infection
- lactating or pregnant females or females of childbearing potential who do not undergo hysterectomy or are not willing to use "effective" method of contraception.
- +5 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Boryung Pharmaceutical Co., Ltdlead
- Kyungpook National University Hospitalcollaborator
- The Catholic University of Koreacollaborator
- Cheil General Hospital and Women's Healthcare Centercollaborator
- Inje Universitycollaborator
- Keimyung Universitycollaborator
- Seoul National University Bundang Hospitalcollaborator
- Severance Hospitalcollaborator
- Yeungnam University Hospitalcollaborator
Study Sites (1)
Kyungpook National University Hospital
Daegu, 700-721, South Korea
Related Publications (5)
Avanzini F, Palumbo G, Alli C, Roncaglioni MC, Ronchi E, Cristofari M, Capra A, Rossi S, Nosotti L, Costantini C, Pietrofeso R. Effects of low-dose aspirin on clinic and ambulatory blood pressure in treated hypertensive patients. Collaborative Group of the Primary Prevention Project (PPP)--Hypertension study. Am J Hypertens. 2000 Jun;13(6 Pt 1):611-6. doi: 10.1016/s0895-7061(00)00231-4.
PMID: 10912743RESULTMagen E, Viskoper JR, Mishal J, Priluk R, London D, Yosefy C. Effects of low-dose aspirin on blood pressure and endothelial function of treated hypertensive hypercholesterolaemic subjects. J Hum Hypertens. 2005 Sep;19(9):667-73. doi: 10.1038/sj.jhh.1001910.
PMID: 16034448RESULTHermida RC, Fernandez JR, Ayala DE, Mojon A, Iglesias M. Influence of aspirin usage on blood pressure: dose and administration-time dependencies. Chronobiol Int. 1997 Nov;14(6):619-37. doi: 10.3109/07420529709001452.
PMID: 9360028RESULTHermida RC, Ayala DE, Iglesias M. Administration time-dependent influence of aspirin on blood pressure in pregnant women. Hypertension. 2003 Mar;41(3 Pt 2):651-6. doi: 10.1161/01.HYP.0000047876.63997.EE. Epub 2002 Dec 9.
PMID: 12623974RESULTHypertension 2005;46[part2]:1060-1068
RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Shung Chull Chae, Professor
Kyungpook National University Hospital
- PRINCIPAL INVESTIGATOR
Dong Ju Choi, Professor
Seoul National University Bundang Hospital
- PRINCIPAL INVESTIGATOR
Dong Su Kim, Professor
Inje University
- PRINCIPAL INVESTIGATOR
Jeong Bae Park, Professor
Cheil General Hospital and Women's Healthcare Center
- PRINCIPAL INVESTIGATOR
Nam Sik Chung, Professor
Severance Hospital
- PRINCIPAL INVESTIGATOR
Sang Hong Baek, Professor
The Catholic University of Korea
- PRINCIPAL INVESTIGATOR
Chang Wook Nam, Professor
Keimyung University Dongsan Medical Center
- PRINCIPAL INVESTIGATOR
Young Jo Kim, Professor
Yeungnam University Hospital
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- INDUSTRY
Study Record Dates
First Submitted
October 9, 2006
First Posted
October 11, 2006
Study Start
September 1, 2006
Primary Completion
January 1, 2007
Study Completion
August 1, 2008
Last Updated
December 15, 2010
Record last verified: 2010-12